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BACKGROUND: Evaluations of the impact of hospital
accreditation have been previously hampered by the lack of
nationally standardized data. One way to assess this impact
is to compare accreditation status with other evidence-
based measures of quality, such as the process measures
now publicly reported by The Joint Commission and the
Centers for Medicare and Medicaid Services (CMS).
OBJECTIVES: To examine the association between Joint
Commission accreditation status and both absolute
measures of, and trends in, hospital performance on
publicly reported quality measures for common diseases.
DESIGN, SETTING, AND PATIENTS: Performance data for
2004 and 2008 from U.S. acute care and critical access
hospitals were obtained using publicly available CMS
Hospital Compare data augmented with Joint Commission
performance data.
MEASUREMENTS: Changes in hospital performance
between 2004 and 2008, and percent of hospitals with 2008
performance exceeding 90% for 16 measures of quality-of-
care and 4 summary scores.
RESULTS: Hospitals accredited by The Joint Commission
tended to have better baseline performance in 2004 than
non-accredited hospitals. Accredited hospitals had larger
gains over time, and were signiﬁcantly more likely to have
high performance in 2008 on 13 out of 16 standardized
clinical performance measures and all summary scores.
CONCLUSIONS: While Joint Commission-accredited
hospitals already outperformed non-accredited hospitals
on publicly reported quality measures in the early days of
public reporting, these differences became signiﬁcantly
more pronounced over 5 years of observation. Future
research should examine whether accreditation actually
promotes improved performance or is a marker for other
hospital characteristics associated with such performance.
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The Joint Commission (TJC) currently accredits
approximately 4546 acute care, critical access, and
specialty hospitals,
1 accounting for approximately
82% of U.S. hospitals (representing 92% of hospital
beds). Hospitals seeking to earn and maintain ac-
creditation undergo unannounced on-site visits by a
team of Joint Commission surveyors at least once
every 3 years. These surveys address a variety of
domains, including the environment of care, infec-
tion prevention and control, information manage-
ment, adherence to a series of national patient safety
goals, and leadership.
1
The survey process has changed markedly in recent
years. Since 2002, accredited hospitals have been
required to continuously collect and submit selected
performance measure data to The Joint Commission
throughout the three-year accreditation cycle. The
tracer methodology, an evaluation method in which
surveyors select a patient to follow through the orga-
nization in order to assess compliance with selected
standards, was instituted in 2004. Soon thereafter,
on-site surveys went from announced to unannounced
in 2006.
Despite the 50þ year history of hospital accredita-
tion in the United States, there has been surprisingly
little research on the link between accreditation status
and measures of hospital quality (both processes and
outcomes). It is only recently that a growing number
of studies have attempted to examine this relationship.
Empirical support for the relationship between accred-
itation and other quality measures is emerging.
Accredited hospitals have been shown to provide bet-
ter emergency response planning
2 and training
3 com-
pared to non-accredited hospitals. Accreditation has
been observed to be a key predictor of patient safety
system implementation
4 and the primary driver of
hospitals’ patient-safety initiatives.
5 Accredited trauma
centers have been associated with signiﬁcant reduc-
tions in patient mortality,
6 and accreditation has been
linked to better compliance with evidence-based meth-
adone and substance abuse treatment.
7,8 Accredited
hospitals have been shown to perform better on meas-
ures of hospital quality in acute myocardial infarction
(AMI), heart failure, and pneumonia care.
9,10 Simi-
larly, accreditation has been associated with lower
risk-adjusted in-hospital mortality rates for congestive
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11,12 The
results of such research, however, have not always
been consistent. Several studies have been unable to
demonstrate a relationship between accreditation and
quality measures. A study of ﬁnancial and cost-related
outcome measures found no relationship to accredita-
tion,
13 and a study comparing medication error rates
across different types of organizations found no rela-
tionship to accreditation status.
14 Similarly, a compar-
ison of accredited versus non-accredited ambulatory
surgical organizations found that patients were less
likely to be hospitalized when treated at an accredited
facility for colonoscopy procedures, but no such rela-
tionship was observed for the other 4 procedures
studied.
15
While the research to date has been generally sup-
portive of the link between accreditation and other
measures of health care quality, the studies were typi-
cally limited to only a few measures and/or involved
relatively small samples of accredited and non-accred-
ited organizations. Over the last decade, however,
changes in the performance measurement landscape
have created previously unavailable opportunities to
more robustly examine the relationship between ac-
creditation and other indicators of hospital quality.
At about the same time that The Joint Commis-
sion’s accreditation process was becoming more vig-
orous, the Centers for Medicare and Medicaid Serv-
ices (CMS) began a program of publicly reporting
quality data (http://www.
hospitalcompare.hhs.gov). The alignment of Joint
Commission and CMS quality measures establishes a
mechanism through which accredited and non-
accredited hospitals can be compared using the same
nationally standardized quality measures. Therefore,
we took advantage of this unique circumstance—a
new and more robust TJC accreditation program and
the launching of public quality reporting—to exam-
ine the relationship between Joint Commission ac-
creditation status and publicly reported hospital
quality measures. Moreover, by examining trends in
these publicly reported measures over ﬁve years and
incorporating performance data not found in the
Hospital Compare Database, we assessed whether ac-
creditation status was also linked to the pace of per-
formance improvement over time.
By using a population of hospitals and a range of
standardized quality measures greater than those used
in previous studies, we seek to address the following
questions: Is Joint Commission accreditation status
truly associated with higher quality care? And does ac-
creditation status help identify hospitals that are more
likely to improve their quality and safety over time?
METHODS
Performance Measures
Since July 2002, U.S. hospitals have been collecting
data on standardized measures of quality developed by
The Joint Commission and CMS. These measures have
been endorsed by the National Quality Forum
16 and
adopted by the Hospital Quality Alliance.
17 The ﬁrst
peer-reviewed reports using The Joint Commission/
CMS measure data conﬁrmed that the measures could
successfully monitor and track hospital improvement
and identify disparities in performance,
18,19 as called
for by the Institute of Medicine’s (IOM) landmark
2001 report, Crossing the Quality Chasm.
20
In order to promote transparency in health care,
both CMS—through the efforts of the Hospital Quality
Alliance—and The Joint Commission began publicly
reporting measure rates in 2004 using identical mea-
sure and data element speciﬁcations. It is important to
note that during the ﬁve-year span covered by this
study, both The Joint Commission and CMS empha-
sized the reporting of performance measure data.
While performance improvement has been the clear
objective of these efforts, neither organization estab-
lished targets for measure rates or set benchmarks for
performance improvement. Similarly, while Joint
Commission-accredited hospitals were required to
submit performance measure data as a condition of
accreditation, their actual performance on the mea-
sure rates did not factor into the accreditation deci-
sion. In the absence of such direct leverage, it is inter-
esting to note that several studies have demonstrated
the positive impact of public reporting on hospital
performance,
21 and on providing useful information
to the general public and health care professionals
regarding hospital quality.
22
The 16 measures used in this study address hospital
compliance with evidence-based processes of care rec-
ommended by the clinical treatment guidelines of
respected professional societies.
23 Process of care
measures are particularly well suited for quality
improvement purposes, as they can identify deﬁcien-
cies which can be immediately addressed by hospitals
and do not require risk-adjustment, as opposed to out-
come measures, which do not necessarily directly iden-
tify obvious performance improvement opportuni-
ties.
24–26 The measures were also implemented in sets
in order to provide hospitals with a more complete
portrayal of quality than might be provided using
unrelated individual measures. Research has demon-
strated that greater collective performance on these
process measures is associated with improved one-
year survival after heart failure hospitalization
27 and
inpatient mortality for those Medicare patients dis-
charged with acute myocardial infarction, heart fail-
ure, and pneumonia,
28 while other research has shown
little association with short-term outcomes.
29
Using the Speciﬁcations Manual for National Hospi-
tal Inpatient Quality Measures,
16 hospitals identify the
initial measure populations through International Clas-
siﬁcation of Diseases (ICD-CM-9) codes and patient
age obtained through administrative data. Trained
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data elements through medical record review on the
identiﬁed measure population or a sample of this popu-
lation. Measure algorithms then identify patients in the
numerator and denominator of each measure.
Process measure rates reﬂect the number of times a
hospital treated a patient in a manner consistent with
speciﬁc evidence-based clinical practice guidelines (nu-
merator cases), divided by the number of patients
who were eligible to receive such care (denominator
cases). Because precise measure speciﬁcations permit
the exclusion of patients contraindicated to receive the
speciﬁc process of care for the measure, ideal perform-
ance should be characterized by measure rates that
approach 100% (although rare or unpredictable situa-
tions, and the reality that no measure is perfect in its
design, make consistent performance at 100%
improbable). Accuracy of the measure data, as meas-
ured by data element agreement rates on reabstrac-
tion, has been reported to exceed 90%.
30
In addition to the individual performance measures,
hospital performance was assessed using 3 condition-
speciﬁc summary scores, one for each of the 3 clinical
areas: acute myocardial infarction, heart failure, and
pneumonia. The summary scores are a weighted av-
erage of the individual measure rates in the clinical
area, where the weights are the sample sizes for each
of the measures.
31 A summary score was also calcu-
lated based on all 16 measures as a summary mea-
sure of overall compliance with recommended care.
One way of studying performance measurement in a
way that relates to standards is to evaluate whether a
hospital achieves a high rate of performance, where
high is deﬁned as a performance rate of 90% or more.
In this context, measures were created from each of
the 2004 and 2008 hospital performance rates by
dichotomizing them as being either less than 90%, or
greater than or equal to 90%.
32
Data Sources
The data for the measures included in the study are
available on the CMS Hospital Compare public data-
bases or The Joint Commission for discharges in 2004
and 2008.
33 These 16 measures, active for all 5 years
of the study period, include: 7 measures related to
acute myocardial infarction care; 4 measures related
to heart failure care; and 5 measures related to pneu-
monia care. The majority of the performance data for
the study were obtained from the yearly CMS Hospi-
tal Compare public download databases (http://
www.medicare.gov/Download/DownloadDB.asp).
When hospitals only reported to The Joint Commis-
sion (154 hospitals; of which 118 are Veterans
Administration and 30 are Department of Defense
hospitals), data were obtained from The Joint Com-
mission’s ORYX database, which is available for pub-
lic download on The Joint Commission’s Quality
Check web site.
23 Most accredited hospitals partici-
pated in Hospital Compare (95.5% of accredited hos-
pitals in 2004 and 93.3% in 2008).
Hospital Characteristics
We then linked the CMS performance data, aug-
mented by The Joint Commission performance data
when necessary, to hospital characteristics data in the
American Hospital Association (AHA) Annual Survey
with respect to proﬁt status, number of beds (<100
beds, 100–299 beds, 300þ beds), rural status, geo-
graphic region, and whether or not the hospital was a
critical access hospital. (Teaching status, although
available in the AHA database, was not used in the
analysis, as almost all teaching hospitals are Joint
Commission accredited.) These characteristics were
chosen since previous research has identiﬁed them as
being associated with hospital quality.
9,19,34–37 Data
on accreditation status were obtained from The Joint
Commission’s hospital accreditation database. Hospi-
tals were grouped into 3 hospital accreditation strata
based on longitudinal hospital accreditation status
between 2004 and 2008: 1) hospitals not accredited in
the study period; 2) hospitals accredited between one
to four years; and 3) hospitals accredited for the entire
study period. Analyses of this middle group (those
hospitals accredited for part of the study period; n ¼
212, 5.4% of the whole sample) led to no signiﬁcant
change in our ﬁndings (their performance tended to be
midway between always accredited and never-accred-
ited hospitals) and are thus omitted from our results.
Instead, we present only hospitals who were never
accredited (n ¼ 762) and those who were accredited
through the entire study period (n ¼ 2917).
Statistical Analysis
We assessed the relationship between hospital charac-
teristics and 2004 performance of Joint Commission-
accredited hospitals with hospitals that were not Joint
Commission accredited using v
2 tests for categorical
variables and t tests for continuous variables. Linear
regression was used to estimate the ﬁve-year change in
performance at each hospital as a function of accredi-
tation group, controlling for hospital characteristics.
Baseline hospital performance was also included in
the regression models to control for ceiling effects for
those hospitals with high baseline performance. To
summarize the results, we used the regression models
to calculate adjusted change in performance for each
accreditation group, and calculated a 95% conﬁdence
interval and P value for the difference between the
adjusted change scores, using bootstrap methods.
38
Next we analyzed the association between accredita-
tion and the likelihood of high 2008 hospital perform-
ance by dichotomizing the hospital rates, using a 90%
cut point, and using logistic regression to estimate the
probability of high performance as a function of ac-
creditation group, controlling for hospital characteris-
tics and baseline hospital performance. The logistic
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high performance for each accreditation group in pre-
senting the results.
We used two-sided tests for signiﬁcance; P < 0.05
was considered statistically signiﬁcant. This study had
no external funding source.
RESULTS
For the 16 individual measures used in this study, a
total of 4798 hospitals participated in Hospital Com-
pare or reported data to The Joint Commission in
2004 or 2008. Of these, 907 were excluded because
the performance data were not available for either
2004 (576 hospitals) or 2008 (331 hospitals) resulting
in a missing value for the change in performance
score. Therefore, 3891 hospitals (81%) were included
in the ﬁnal analyses. The 907 excluded hospitals were
more likely to be rural (50.8% vs 17.5%), be critical
access hospitals (53.9% vs 13.9%), have less than 100
beds (77.4% vs 37.6%), be government owned
(34.6% vs 22.1%), be for proﬁt (61.4% vs 49.5%),
or be unaccredited (79.8% vs 45.8% in 2004; 75.6%
vs 12.8% in 2008), compared with the included hos-
pitals (P < 0.001 for all comparisons).
Hospital Performance at Baseline
Joint Commission-accredited hospitals were more
likely to be large, for proﬁt, or urban, and less likely
to be government owned, from the Midwest, or criti-
cal access (Table 1). Non-accredited hospitals per-
formed more poorly than accredited hospitals on most
of the publicly reported measures in 2004; the only
exception is the timing of initial antibiotic therapy
measure for pneumonia (Table 2).
TABLE 1. Hospital Characteristics in 2004 Stratiﬁed
by Joint Commission Accreditation Status
Characteristic
Non-Accredited
(n ¼ 786)
Accredited
(n ¼ 3105)
P
Value*
Proﬁt status, No. (%) <0.001
For proﬁt 60 (7.6) 586 (18.9)
Government 289 (36.8) 569 (18.3)
Not for proﬁt 437 (55.6) 1,950 (62.8)
Census region, No. (%) <0.001
Northeast 72 (9.2) 497 (16.0)
Midwest 345 (43.9) 716 (23.1)
South 248 (31.6) 1,291 (41.6)
West 121 (15.4) 601 (19.4)
Rural setting, No. (%) <0.001
Rural 495 (63.0) 833 (26.8)
Urban 291 (37.0) 2,272 (73.2)
Bed size <0.001
<100 beds 603 (76.7) 861 (27.7)
100–299 beds 158 (20.1) 1,444 (46.5)
300þ beds 25 (3.2) 800 (25.8)
Critical access hospital status, No. (%) <0.001
Critical access hospital 376 (47.8) 164 (5.3)
Acute care hospital 410 (52.2) 2,941 (94.7)
*P values based on v
2 for categorical variables.
TABLE 2. Hospital Raw Performance in 2004 and 2008, Stratiﬁed by Joint Commission Accreditation Status
Quality Measure, Mean (SD)*
2004 2008
Non-Accredited Accredited
P Value
†
Non-Accredited Accredited
P Value
† (n ¼ 786) (n ¼ 3105) (n ¼ 950) (n ¼ 2,941)
AMI
Aspirin at admission 87.1 (20.0) 92.6 (9.4) <0.001 88.6 (22.1) 96.0 (8.6) <0.001
Aspirin at discharge 81.2 (26.1) 88.5 (14.9) <0.001 87.8 (22.7) 94.8 (10.1) <0.001
ACE inhibitor for LV dysfunction 72.1 (33.4) 76.7 (22.9) 0.010 83.2 (30.5) 92.1 (14.8) <0.001
Beta blocker at discharge 78.2 (27.9) 87.0 (16.2) <0.001 87.4 (23.4) 95.5 (9.9) <0.001
Smoking cessation advice 59.6 (40.8) 74.5 (29.9) <0.001 87.2 (29.5) 97.2 (11.3) <0.001
PCI received within 90 min 60.3 (26.2) 60.6 (23.8) 0.946 70.1 (24.8) 77.7 (19.2) 0.006
Thrombolytic agent within 30 min 27.9 (35.5) 32.1 (32.8) 0.152 31.4 (40.7) 43.7 (40.2) 0.008
Composite AMI score 80.6 (20.3) 87.7 (10.4) <0.001 85.8 (20.0) 94.6 (8.1) <0.001
Heart failure
Discharge instructions 36.8 (32.3) 49.7 (28.2) <0.001 67.4 (29.6) 82.3 (16.4) <0.001
Assessment of LV function 63.3 (27.6) 83.6 (14.9) <0.001 79.6 (24.4) 95.6 (8.1) <0.001
ACE inhibitor for LV dysfunction 70.8 (27.6) 75.7 (16.3) <0.001 82.5 (22.7) 91.5 (9.7) <0.001
Smoking cessation advice 57.1 (36.4) 68.6 (26.2) <0.001 81.5 (29.9) 96.1 (10.7) <0.001
Composite heart failure score 56.3 (24.1) 71.2 (15.6) <0.001 75.4 (22.3) 90.4 (9.4) <0.001
Pneumonia
Oxygenation assessment 97.4 (7.3) 98.4 (4.0) <0.001 99.0 (3.2) 99.7 (1.2) <0.001
Pneumococcal vaccination 45.5 (29.0) 48.7 (26.2) 0.007 79.9 (21.3) 87.9 (12.9) <0.001
Timing of initial antibiotic therapy 80.6 (13.1) 70.9 (14.0) <0.001 93.4 (9.2) 93.6 (6.1) 0.525
Smoking cessation advice 56.6 (33.1) 65.7 (24.8) <0.001 81.6 (25.1) 94.4 (11.4) <0.001
Initial antibiotic selection 73.6 (19.6) 74.1 (13.4) 0.508 86.1 (13.8) 88.6 (8.7) <0.001
Composite pneumonia score 77.2 (10.2) 76.6 (8.2) 0.119 90.0 (9.6) 93.6 (4.9) <0.001
Overall composite 73.7 (10.6) 78.0 (8.7) <0.001 86.8 (11.1) 93.3 (5.0) <0.001
Abbreviations: ACE, angiotensin-converting enzyme; AMI, acute myocardial infarction; LV, left ventricular; PCI, percutaneous coronary intervention.
*Calculated as the proportion of all eligible patients who received the indicated care.
†P values based on t tests.
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Between 2004 and 2008, Joint Commission-accredited
hospitals improved their performance more than did
non-accredited hospitals (Table 3). After adjustment
for baseline characteristics previously shown to be
associated with performance, the overall relative
(absolute) difference in improvement was 26% (4.2%)
(AMI score difference 67% [3.9%], CHF 48%
[10.1%], and pneumonia 21% [3.7%]). Accredited
hospitals improved their performance signiﬁcantly
more than non-accredited for 13 of the 16 individual
performance measures.
High Performing Hospitals in 2008
The likelihood that a hospital was a high performer in
2008 was signiﬁcantly associated with Joint Commis-
sion accreditation status, with a higher proportion of
accredited hospitals reaching the 90% threshold com-
pared to never-accredited hospitals (Table 4). Accred-
ited hospitals attained the 90% threshold signiﬁcantly
more often for 13 of the 16 performance measures
and all four summary scores, compared to non-accred-
ited hospitals. In 2008, 82% of Joint Commission-
accredited hospitals demonstrated greater than 90%
on the overall summary score, compared to 48% of
never-accredited hospitals. Even after adjusting for
differences among hospitals, including performance at
baseline, Joint Commission-accredited hospitals were
more likely than never-accredited hospitals to exceed
90% performance in 2008 (84% vs 69%).
DISCUSSION
While accreditation has face validity and is desired by
key stakeholders, it is expensive and time consuming.
Stakeholders thus are justiﬁed in seeking evidence that
accreditation is associated with better quality and
safety. Ideally, not only would it be associated with
better performance at a single point in time, it would
also be associated with the pace of improvement over
time.
Our study is the ﬁrst, to our knowledge, to show
the association of accreditation status with improve-
ment in the trajectory of performance over a ﬁve-year
period. Taking advantage of the fact that the accredi-
tation process changed substantially at about the same
time that TJC and CMS began requiring public
reporting of evidence-based quality measures, we
found that hospitals accredited by The Joint Commis-
sion had had larger improvements in hospital per-
formance from 2004 to 2008 than non-accredited hos-
pitals, even though the former started with higher
baseline performance levels. This accelerated improve-
ment was broad-based: Accredited hospitals were
more likely to achieve superior performance (greater
than 90% adherence to quality measures) in 2008 on
13 of 16 nationally standardized quality-of-care meas-
ures, three clinical area summary scores, and an
TABLE 3. Performance Change and Difference in Performance Change From 2004 to 2008 by Joint Commission
Accreditation Status
Characteristic
Change in Performance*
Absolute Difference,
Always vs Never (95% CI)
†
Relative Difference,
% Always vs Never P Value
†
Never Accredited
(n ¼ 762)
Always Accredited
(n ¼ 2,917)
AMI
Aspirin at admission  1.1 2.0 3.2 (1.2–5.2) 160 0.001
Aspirin at discharge 4.7 8.0 3.2 (1.4–5.1) 40 0.008
ACE inhibitor for LV dysfunction 8.5 15.9 7.4 (3.7–11.5) 47 <0.001
Beta blocker at discharge 4.4 8.4 4.0 (2.0–6.0) 48 <0.001
Smoking cessation advice 18.6 22.4 3.7 (1.1–6.9) 17 0.012
PCI received within 90 min 6.3 13.0 6.7 (0.3–14.2) 52 0.070
Thrombolytic agent within 30 min  0.6 5.4 6.1 ( 9.5–20.4) 113 0.421
Composite AMI score 2.0 5.8 3.9 (2.2–5.5) 67 <0.001
Heart failure
Discharge instructions 24.2 35.6 11.4 (8.7–14.0) 32 <0.001
Assessment of LV function 4.6 12.8 8.3 (6.6–10.0) 65 <0.001
ACE inhibitor for LV dysfunction 10.1 15.2 5.1 (3.5–6.8) 34 <0.001
Smoking cessation advice 20.5 26.4 6.0 (3.3–8.7) 23 <0.001
Composite heart failure score 10.8 20.9 10.1 (8.3–12.0) 48 <0.001
Pneumonia
Oxygenation assessment 0.9 1.4 0.6 (0.3–0.9) 43 <0.001
Pneumococcal vaccination 33.4 40.9 7.5 (5.6–9.4) 18 <0.001
Timing of initial antibiotic therapy 19.2 21.1 1.9 (1.1–2.7) 9 <0.001
Smoking cessation advice 21.8 27.9 6.0 (3.8–8.3) 22 <0.001
Initial antibiotic selection 13.6 14.3 0.7 ( 0.5–1.9) 5 0.293
Composite pneumonia score 13.7 17.5 3.7 (2.8–4.6) 21 <0.001
Overall composite 12.0 16.1 4.2 (3.2–5.1) 26 <0.001
Abbreviations: ACE angiotensin-converting enzyme; AMI, acute myocardial infarction; CI, conﬁdence interval; LV, left ventricular; PCI, percutaneous coronary intervention. *Performance calculated as the proportion of all eligible
patients who received the indicated care. Change in performance estimated based on multivariate regression adjusting for baseline performance, proﬁt status, bed size, rural setting, critical access hospital status, and region
except for PCI received within 90 minutes and thrombolytic agent within 30 minutes which did not adjust for critical access hospital status.
†P values and CIs calculated based on bootstrapped standard errors.
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accredited. These results are consistent with other
studies that have looked at both process and outcome
measures and accreditation.
9–12
It is important to note that the observed ‘‘accredita-
tion effect’’ reﬂects a difference between hospitals that
have elected to seek one particular ‘‘self-regulatory al-
ternative to the more restrictive and extensive public
regulatory or licensure requirements’’ with those that
have not.
39 The non-accredited hospitals that were
included in this study are not considered to be ‘‘sub-
standard hospitals.’’ In fact, hospitals not accredited
by The Joint Commission have also met the standards
set by Medicare in the Conditions of Participation,
and our study demonstrates that these hospitals
achieved reasonably strong performance on publicly
reported quality measures (86.8% adherence on the
composite measure in 2008) and considerable
improvement over the 5 years of public reporting (av-
erage improvement on composite measure from 2004
to 2008 of 11.8%). Moreover, there are many paths
to improvement, and some non-accredited hospitals
achieve stellar performance on quality measures, per-
haps by embracing other methods to catalyze
improvement.
That said, our data demonstrate that, on average,
accredited hospitals achieve superior performance on
these evidence-based quality measures, and their per-
formance improved more strikingly over time. In
interpreting these results, it is important to recognize
that, while Joint Commission-accredited hospitals
must report quality data, performance on these meas-
ures is not directly factored into the accreditation de-
cision; if this were not so, one could argue that this
association is a statistical tautology. As it is, we
believe that the 2 measures (accreditation and publicly
reported quality measures) are two independent
assessments of the quality of an organization, and,
while the performance measures may not be a ‘‘gold
standard,’’ a measure of their association does provide
useful information about the degree to which accredi-
tation is linked to organizational quality.
There are several potential limitations of the current
study. First, while we adjusted for most of the known
hospital demographic and organizational factors asso-
ciated with performance, there may be unidentiﬁed
factors that are associated with both accreditation and
performance. This may not be relevant to a patient or
payer choosing a hospital based on accreditation sta-
tus (who may not care whether accreditation is simply
associated with higher quality or actually helps pro-
duce such quality), but it is relevant to policy-makers,
who may weigh the value of embracing accreditation
versus other maneuvers (such as pay for performance
or new educational requirements) as a vehicle to pro-
mote high-quality care.
A second limitation is that the speciﬁcation of the
measures can change over time due to the acquisition
TABLE 4. Percent of Hospitals With High Performance* in 2008 by Joint Commission Accreditation Status
Characteristic
Percent of Hospitals with Performance
Over 90%
† Adjusted (Actual)
Odds Ratio, Always vs
Never (95% CI)
† P Value
† Never Accredited (n ¼ 762) Always Accredited (n ¼ 2,917)
AMI
Aspirin at admission 91.8 (71.8) 93.9 (90.7) 1.38 (1.00–1.89) 0.049
Aspirin at discharge 83.7 (69.2) 88.2 (85.1) 1.45 (1.08–1.94) 0.013
ACE inhibitor for LV dysfunction 65.1 (65.8) 77.2 (76.5) 1.81 (1.32–2.50) <0.001
Beta blocker at discharge 84.7 (69.4) 90.9 (88.4) 1.80 (1.33–2.44) <0.001
Smoking cessation advice 91.1 (81.3) 95.9 (94.1) 2.29 (1.31–4.01) 0.004
PCI received within 90 min 21.5 (16.2) 29.9 (29.8) 1.56 (0.71–3.40) 0.265
Thrombolytic agent within 30 min 21.4 (21.3) 22.7 (23.6) 1.08 (0.42–2.74) 0.879
Composite AMI score 80.5 (56.6) 88.2 (85.9) 1.82 (1.37–2.41) <0.001
Heart failure
Discharge instructions 27.0 (26.3) 38.9 (39.3) 1.72 (1.30–2.27) <0.001
Assessment of LV function 76.2 (45.0) 89.1 (88.8) 2.54 (1.95–3.31) <0.001
ACE inhibitor for LV dysfunction 58.0 (51.4) 67.8 (68.5) 1.52 (1.21–1.92) <0.001
Smoking cessation advice 84.2 (62.3) 90.3 (89.2) 1.76 (1.28–2.43) <0.001
Composite heart failure score 38.2 (27.6) 61.5 (64.6) 2.57 (2.03–3.26) <0.001
Pneumonia
Oxygenation assessment 100 (98.2) 100 (99.8) 4.38 (1.20–1.32) 0.025
Pneumococcal vaccination 44.1 (40.3) 57.3 (58.2) 1.70 (1.36–2.12) <0.001
Timing of initial antibiotic therapy 74.3 (79.1) 84.2 (82.7) 1.85 (1.40–2.46) <0.001
Smoking cessation advice 76.2 (54.6) 85.8 (84.2) 1.89 (1.42–2.51) <0.001
Initial antibiotic selection 51.8 (47.4) 51.0 (51.8) 0.97 (0.76–1.25) 0.826
Composite pneumonia score 69.3 (59.4) 85.3 (83.9) 2.58 (2.01–3.31) <0.001
Overall composite 69.0 (47.5) 83.8 (82.0) 2.32 (1.76–3.06) <0.001
Abbreviations: ACE angiotensin-converting enzyme; AMI, acute myocardial infarction; CI, conﬁdence interval; LV, left ventricular; PCI, percutaneous coronary intervention. *High performance deﬁned as performance rates of
90% or more.
†Performance calculated as the proportion of all eligible patients who received the indicated care. Percent of hospitals with performance over 90% estimated based on multivariate logistic regression adjusting for
baseline performance, proﬁt status, bed size, rural setting, critical access hospital status, and region except for PCI received within 90 minutes and thrombolytic agent within 30 minutes which did not adjust for critical access hos-
pital status. Odds ratios, CIs, and P values based on the logistic regression analysis.
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comparison and tracking of results over time difﬁcult.
There were two measures that had deﬁnitional
changes that had noticeable impact on longitudinal
trends: the AMI measure ‘‘Primary Percutaneous Cor-
onary Intervention (PCI) Received within 90 Minutes
of Hospital Arrival’’ (which in 2004 and 2005 used
120 minutes as the threshold), and the pneumonia
measure ‘‘Antibiotic Within 4 Hours of Arrival’’
(which in 2007 changed the threshold to six hours).
Other changes included adding angiotensin-receptor
blocker therapy (ARB) as an alternative to angioten-
sin-converting enzyme inhibitor (ACEI) therapy in
2005 to the AMI and heart failure measures ACEI or
ARB for left ventricular dysfunction. Other less signif-
icant changes have been made to the data collection
methods for other measures, which could impact the
interpretation of changes in performance over time.
That said, these changes inﬂuenced both accredited
and non-accredited hospitals equally, and we cannot
think of reasons that they would have created differ-
ential impacts.
Another limitation is that the 16 process measures
provide a limited picture of hospital performance.
Although the three conditions in the study account for
over 15% of Medicare admissions,
19 it is possible that
non-accredited hospitals performed as well as accred-
ited hospitals on other measures of quality that were
not captured by the 16 measures. As more standar-
dized measures are added to The Joint Commission
and CMS databases, it will be possible to use the
same study methodology to incorporate these addi-
tional domains.
From the original cohort of 4798 hospitals reporting
in 2004 or 2008, 19% were not included in the study
due to missing data in either 2004 or 2008. Almost
two-thirds of the hospitals excluded from the study
were missing 2004 data and, of these, 77% were criti-
cal access hospitals. The majority of these critical
access hospitals (97%) were non-accredited. This is in
contrast to the hospitals missing 2008 data, of which
only 13% were critical access. Since reporting of data
to Hospital Compare was voluntary in 2004, it
appears that critical access hospitals chose to wait
later to report data to Hospital Compare, compared
to acute care hospitals. Since critical access hospitals
tended to have lower rates, smaller sample sizes, and
be non-accredited, the results of the study would be
expected to slightly underestimate the difference
between accredited and non-accredited hospitals.
Finally, while we have argued that the publicly
reported quality measures and TJC accreditation deci-
sions provide different lenses into the quality of a
given hospital, we cannot entirely exclude the possibil-
ity that there are subtle relationships between these
two methods that might be partly responsible for our
ﬁndings. For example, while performance measure
rates do not factor directly into the accreditation deci-
sion, it is possible that Joint Commission surveyors
may be inﬂuenced by their knowledge of these rates
and biased in their scoring of unrelated standards dur-
ing the survey process. While we cannot rule out such
biases, we are aware of no research on the subject,
and have no reason to believe that such biases may
have confounded the analysis.
In summary, we found that Joint Commission-
accredited hospitals outperformed non-accredited hos-
pitals on nationally standardized quality measures of
AMI, heart failure, and pneumonia. The performance
gap between Joint Commission-accredited and non-
accredited hospitals increased over the ﬁve years of
the study. Future studies should incorporate more ro-
bust and varied measures of quality as outcomes, and
seek to examine the nature of the observed relation-
ship (ie, whether accreditation is simply a marker of
higher quality and more rapid improvement, or the
accreditation process actually helps create these salu-
tary outcomes).
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